Retinopathy drugs in development, 2023

GlobalData tracks 198 drugs in development for Retinopathy by 163 companies/universities/institutes. The top development phase for Retinopathy is preclinical, with 131 drugs in that stage.

Pα+ Psychedelic Bulletin #153: MindMed Scraps Microdosing Program; Eagerly Anticipated Ibogaine Study Publishes; Compass Collaborates with Greenbrook; Gilgamesh’s GM-1020 Readout; and more… – Psychedelic Alpha

This Issue is a relatively long one, as it’s something of a catch-up for the holiday period. We look at psychedelic drug development news from

January 12, 2024

Biopharma at a Crossroads: AI Offers Key to R&D Reinvention

What You Should Know: – A new report by Accenture, “Reinventing R&D in the Age of AI,” paints a clear picture: the biopharmaceutical industry stands

July 2, 2024

Researchers develop new antibody with potential to treat several types of cancer

Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the potential to treat

November 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.